Shkreli Subpoenaed by Congress

Stephen L Kanaval |

Hipster super-villain, Martin Shkreli, has been summoned to a congressional hearing next Tuesday for excessive increases in the pharmaceutical sector. The House Committee on Oversight and Government Reform are investigating several drug companies over price-gouging. Shkreli was just arrested last month for charges of security fraud, but was released on $5 million bail.

Chairman Jason Chaffetz, a Republican from Utah, issued the summons. Chaffetz as well as Elijah Cummings, a Democrat from Maryland, have tried to obtain information from Turing and Valeant. They were obstructed by Shkreli. Valeant Pharmaceuticals interim CEO, Howard Schiller, will testify in the hearing. Drug price-gouging reached a clamorous fever-pitch when Turing raised the price of Daraprim 5000%. Facing outrage, Shkreli said he would lower the price, but balked. The company only managed to offer patients financial aid to afford the drug treatment.

The House of Representatives made clear to the media and the public that the committee and subpoena were not part of any criminal proceedings. It is unclear if Shkreli will testify. He posted this mocking message to his twitter:






Shkreli also posted a snapshot of the subpoena accompanied with the comment, “Looks important.”

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…